Control integral del cáncer cervicouterino guía de prácticas esenciales

Cervical cancer stands as a formidable threat to women's lives across the globe, claiming hundreds of thousands each year, with the vast majority of these tragedies unfolding in low- and middle-income countries where access to essential services remains tragically limited. This guide lays out a clear, comprehensive vision for confronting this challenge, emphasizing that a coordinated, multi-pronged approach is not merely beneficial, but absolutely vital. It calls for a unified front, demanding collaboration across diverse programs, organizations, and partners to bridge the chasm between urgent needs and available care.

The journey toward eliminating cervical cancer begins with robust prevention, primarily through the Human Papillomavirus (HPV) vaccine. It is imperative to prioritize the vaccination of girls aged 9 to 14 years, ideally before they become sexually active, utilizing a two-dose schedule that has proven as effective as the previous three-dose regimen, thereby easing administration and reducing costs, particularly for resource-constrained nations. This critical intervention safeguards against the high-risk HPV types responsible for the majority of cervical cancers, offering a shield against future disease. Some countries have also begun to vaccinate boys, further contributing to community-wide protection.

Beyond vaccination, the continuum of care extends to meticulous screening and timely treatment of pre-cancerous lesions. Women aged 30 and above in the general population should undergo screening with a high-performance test every 5 to 10 years, while women living with HIV require more frequent screening, starting at age 25 and recurring every 3 to 5 years. The global strategy encourages at least two lifetime screens by ages 35 and 45. These high-performance tests, such as HPV DNA testing, are crucial for identifying those at risk.

Once a positive screening result emerges, swift action is paramount. Healthcare providers must be equipped to implement either a "screen-and-treat" approach, where screening and immediate treatment occur in the same visit, or a "screen, triage and treat" strategy, particularly recommended for women living with HIV. Various effective treatment options exist for pre-cancerous lesions, including thermal ablation, which uses heat to destroy abnormal cells; cryotherapy, employing cold to achieve the same; and excisional procedures like LEEP (large loop excision of the transformation zone) or cone biopsy, which remove affected tissue. These interventions are often quick, with limited discomfort, yet they are profoundly effective in preventing progression to invasive cancer.

Should invasive cervical cancer be diagnosed, the guide underscores the absolute necessity of early detection, accurate diagnosis, and prompt, high-quality treatment. Cervical cancer, if identified at an early stage, is curable. The framework also extends to encompass comprehensive palliative care, ensuring that women facing advanced stages of the disease receive the support and comfort they deserve, upholding dignity throughout their journey. This holistic approach ensures that no woman is left behind, from prevention to cure, and beyond.

Integral to the success of these clinical interventions is robust community mobilization, education, and counselling. It is essential to boost public awareness about cervical cancer, its preventability, and the importance of screening. Strengthening health literacy empowers women to make informed decisions about their health, while improving access to information and services at community, primary, and secondary care levels ensures that knowledge translates into action. These efforts foster an environment where women feel supported and encouraged to seek care, dismantling barriers of fear, stigma, and misinformation.

Ultimately, the aspiration is to achieve ambitious global targets by 2030: ensuring that 90% of eligible girls are fully vaccinated against HPV, 70% of women are screened with a high-performance test at least twice in their lifetimes, and 90% of women identified with cervical disease receive appropriate treatment, including palliative care when needed. Achieving these goals requires unwavering commitment, strategic planning, and the collective will to implement these essential practices across all levels of care, transforming the landscape of women's health and moving closer to a future free from cervical cancer.